Search

Your search keyword '"Drospirenone -- Intellectual property"' showing total 23 results
Start Over Descriptor "Drospirenone -- Intellectual property" Topic oral contraceptives -- intellectual property
23 results on '"Drospirenone -- Intellectual property"'

1. Researchers Submit Patent Application, 'Composite Drug Particles And Uses Thereof', for Approval (USPTO 20240165130)

Subjects
Nandrolone -- Intellectual property, Tixocortol, Drospirenone -- Intellectual property, Corticosteroids -- Intellectual property, Hydroxyprogesterone -- Intellectual property, Ciclesonide, Fludrocortisone, Estropipate -- Intellectual property, Androgens, Drug approval, Physical fitness, Oral contraceptives -- Intellectual property, Health
Abstract

2024 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2024

2. Researchers Submit Patent Application, 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same', for Approval (USPTO 20230372248)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DROUIN, [...]

Published
2023

3. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20230046871)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 MAR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2023

4. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11504334)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 DEC 15 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2022

5. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11491113)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 DEC 1 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2022

6. Researchers Submit Patent Application, 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same', for Approval (USPTO 20220339107)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 NOV 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DROUIN, [...]

Published
2022

7. Patent Application Titled 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' Published Online (USPTO 20220339106)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 NOV 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2022

8. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20220339165)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 NOV 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2022

9. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11452695)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 OCT 20 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Drouin, Dominique (Verrieres-le-Buisson, FR), Perrin, Philippe (Paris, FR), Velada, [...]

Published
2022

10. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11439598)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 OCT 6 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Drouin, Dominique (Verrieres-le-Buisson, FR), Perrin, Philippe (Paris, FR), Velada, [...]

Published
2022

11. Researchers Submit Patent Application, 'Composite Drug Particles And Uses Thereof', for Approval (USPTO 20220257523)

Subjects
Nandrolone -- Intellectual property, Tixocortol, Drospirenone -- Intellectual property, Corticosteroids -- Intellectual property, Hydroxyprogesterone -- Intellectual property, Estropipate -- Intellectual property, Ciclesonide, Fludrocortisone, Androgens, Drug approval, Physical fitness, Oral contraceptives -- Intellectual property, Health
Abstract

2022 SEP 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2022

12. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20220241209)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 AUG 25 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2022

13. Researchers Submit Patent Application, 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same', for Approval (USPTO 20220218615)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 AUG 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DROUIN, [...]

Published
2022

14. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20220192991)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2022

15. Researchers Submit Patent Application, 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same', for Approval (USPTO 20220183984)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 JUL 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors DROUIN, [...]

Published
2022

16. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11351122)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 JUN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2022

17. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11291633)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 APR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Laboratorios Leon Farma SA (Leon, Spain) has been issued patent number 11291632, according to [...]

Published
2022

18. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11291632)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 APR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Laboratorios Leon Farma SA (Leon, Spain) has been issued patent number 11291632, according to [...]

Published
2022

19. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20220040113)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 MAR 3 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2022

20. Patent Application Titled 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' Published Online (USPTO 20210299146)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 OCT 21 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2021

21. Patent Issued for Synthetic progestogens and pharmaceutical compositions comprising the same (USPTO 11123299)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Drouin, Dominique (Verrieres-le-Buisson, FR), Perrin, Philippe (Paris, FR), Velada, [...]

Published
2021

22. 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' in Patent Application Approval Process (USPTO 20210213035)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 AUG 5 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DROUIN, Dominique (Verrieres-le-Buisson, FR); PERRIN, Philippe (Paris, FR); [...]

Published
2021

23. Patent Application Titled 'Synthetic Progestogens And Pharmaceutical Compositions Comprising The Same' Published Online (USPTO 20210128585)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Progesterone -- Intellectual property, Estrogen, Oral contraceptives -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results